• |
  • |
  • |
  • |
Donate

Product

Frequency, Progression, and Current Management: Report of 16 New Cases of Nonfunctional Pancreatic Neuroendocrine Tumors in Tuberous Sclerosis Complex and Comparison With Previous Reports

Center:
Fiscal Year:
2021
Contact Information:
Product Description:
Our purpose is to calculate the frequency of nonfunctional PNETs as well as characterize the presentation, current clinical management, and assess the impact of systemic mammalian target of rapamycin (mTOR) on nonfunctional PNETs in TSC.
Keyword(s):
abdominal imaging, nonfunctional, pancreatic neuroendocrine tumor, surveillance, tuberous sclerosis
Product/Publication Type(s):
Peer-reviewed publications in scholarly journals Published/In Press
Target Audience:
Consumers/Families, Professionals, Policymakers, Students
Alternative Format:
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A